Professor Farzin Farzaneh

King’s College London
Professor of Molecular Medicine, Director of Cell and Gene Therapy

Farzin Farzaneh D.Phil., FRCPath., FRSB
Professor of Molecular Medicine, and Director of Cell and Gene Therapy – King’s.
Consultant in Specialist Medicine, King’s College Hospital

Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has published over 250 research articles with an average citation of over 30, and an Impact Factor of 47. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy based investigational medicinal products. Farzin has extensive industrial and academic collaborations, including research council, charitable and pharmaceutical sponsorships of over £25M. He is appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016. He is the recipient of 2016 Distinguished Scientist Award of the US Society for Experimental Biology & Medicine.

dont miss

Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

Cell and gene based therapy of cancer is making major improvements to the treatment of cancer. The development of new strategies for the development of chimeric antigen receptor T cells, genetically modified cancer cell vaccines and therapeutic cancer vaccines for the specific induction of cellular immunity will be described.

Professor Farzin Farzaneh will be speaking in the following theatre:

Theatre 12 - Tuesday 13.15 - 13.45: Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

EVEN MORE SEMINARS

  • Bertil RR Persson: Speaking at the Oncology Convention

    Bertil RR Persson
    Scandinavian ChemoTech AB. Sweden

    Dynamic-ElectroEnhanced Chemotherapy brings relief to patients with large tumour burden

  • Dr Keith Tsui: Speaking at the Oncology Convention

    Dr Keith Tsui
    Medopad

    Remote Patient Monitoring: Bringing the Hospital into the Home

  • James Flanagan: Speaking at the Oncology Convention

    James Flanagan
    Imperial College London

    Epigenetic biomarkers for platinum response in ovarian cancer

  • Jamie Rae: Speaking at the Oncology Convention

    Jamie Rae
    Throat Cancer Foundation

    The Throat Cancer Foundation; how we changed a government’s mind

  • Dr. Omar Milhem: Speaking at the Oncology Convention

    Dr. Omar Milhem
    Pharma Medico Ltd

    Clinical Management of Proteoglycan Follicular Atrophy in Female Hair Loss